CD9 exacerbates pathological cardiac hypertrophy through regulating GP130/STAT3 signaling pathway

Yue Li(First Affiliated Hospital of Zhengzhou University), Zhibo Liu(Beijing National Laboratory for Molecular Sciences)

iScience

September 28, 2023

10.1016/j.isci.2023.108070

Cited by 7

Related Papers

Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial

|The Lancet|2020|3.7k

A corrosion-resistant RuMoNi catalyst for efficient and long-lasting seawater oxidation and anion exchange membrane electrolyzer

|Nature Communications|2023|483

High‐Valence Nickel Single‐Atom Catalysts Coordinated to Oxygen Sites for Extraordinarily Activating Oxygen Evolution Reaction

|Advanced Science|2020|325

Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals

|Cell|2023|236

A highly active and durable electrocatalyst for large current density hydrogen evolution reaction

|Science Bulletin|2019|84